The US District Court for the District of New Jersey has ruled against Merck, known as MSD outside the US and Canada, in a patent litigation against Apotex. The patent at issue in the case covers the active ingredient in Nasonex, ...
Merck, known as MSD outside the US and Canada, has won Zetia (ezetimibe) / Vytorin (ezetimibe/simvastatin) patent infringement suits against Mylan Pharmaceuticals. The US District Court has ruled in favor of Merck in two jointly ...